Millions on common heart drug have 60% lower risk of dying from lethal cancer, study suggests
Statins are Britain's most prescribed medicines, with more than 70 million packs dispensed annually.
Now, scientists in the United Arab Emirates, who tracked more than 1,000 patients with the disease, found those taking the drug were almost two thirds less likely to die from their cancer than those who weren't.
Experts, labelled the findings 'very promising' but cautioned they do not yet prove that statins can 'directly improve cancer outcomes'.
It follows previous research that has suggested taking the medicines may lower the risk of developing up to 20 other types of cancer, including breast, liver, stomach and even bowel.
Dr Ahmad Abuhelwa, an assistant professor of pharmacotherapeutics at the University of Sharjah, said: 'Our results highlight a strong link between statin use and improved survival.
'These findings don't allow us to say for certain that statins directly improve cancer outcomes.
'However, the fact that this association remained strong even after accounting for multiple factors makes it an important area for future research.'
In the study, researchers assessed statin use on patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
Often referred to as the same cancer, both cause white blood cells to develop abnormally, breaking down the body's ability to fight infection.
CLL and SLL are rarely cured completely. Instead, patients live with the cancer, undergoing treatment to control it for as long as possible.
Because the disease develops slowly, doctors have to wait until there is enough cancer in the blood to warrant aggressive treatment.
While patients can be declared cancer-free after chemo, the disease can return, requiring further rounds.
Roughly 80 per cent of patients survive five years or more with the disease.
But according to Lymphoma Action, around 4,500 people are diagnosed with CLL or SLL every year in the UK — more than 12 people each day.
It affects nearly twice as many men as women.
In the study, the scientists tracked 1,467 patients with CLL or SLL, who were aged 65 on average.
Patients were randomly assigned newer cancer therapy drug ibrutinib, either alone or in combination with other anti-cancer drugs.
A third group was put on a drug regimen that did not include ibrutinib.
Around a third of patients were taking a statin at the time they started treatment.
Over a follow-up of roughly five years the researchers found those on statins had a 61 per cent lower risk of dying from their cancer compared to those who were not.
Writing in the journal Blood Advances, they also found patients on the drug had a 38 per cent reduced risk of death from any cause and a 26 per cent reduced risk of disease progression.
The scientists, however, acknowledged the study was merely observational and could not prove why statins may reduce the risk.
The paper also had some 'limitations', they said, including the fact patients use statins at different doses.
'The study could not determine the effects of specific statin types, doses, or duration of use on patients' survival,' they added.
Dr Abuhelwa also said: 'While our results are very promising, we can't recommend starting statins for CLL or SLL treatment based on this study alone.
'Future clinical trials are needed to determine definitively whether statins have a direct benefit on cancer survival.'
Since the drugs first won approval in 1987, global sales of statins have exceeded £765 billion.
The drugs were designed to protect people at high risk of dying from cardiovascular disease. Here, they work by limiting the production of 'bad' low-density lipoprotein (LDL) cholesterol, which can harden or narrow arteries.
They were developed originally for the secondary prevention of heart attacks or strokes — that is, reducing the risk of future events in patients who have already suffered one.
Now they are increasingly used for primary prevention — in people who haven't had a heart attack or stroke, but are deemed to be at risk.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Metro
22-06-2025
- Metro
I had no idea my itchy skin meant I had a deadly disease
For around a year, my skin was so itchy I would scratch it until I bled – even then, I never managed to satisfy the feeling, and it would often keep me awake at night. It never crossed my mind that it could be a symptom of a life-threatening illness. At the same time, I was feeling tired, losing weight, sweating at night, and always coming down with a cold or flu. It was only when I found a lump on my neck that I thought it might be something serious. I often couldn't take a full breath in – this was because a tumour in my chest was about 30 centimetres – but I'd just assumed that it was probably down to something like glandular fever. Consultants usually tell patients their diagnoses in person, so when the doctor said over the phone in September 2018, 'You've got cancer', it was clear time wasn't on our side. 'It's stage 4 Hodgkin Lymphoma in the neck, lung, chest and under the diaphragm. If you'd come to us about a week later, we wouldn't have been able to do anything for you,' he added. The diagnosis left me dumbstruck, like I'd been hit with a freight train. How did this happen? I was only 26. After I put the phone down to my doctor, I said to my mum and dad, 'Can you take me to the hospital because I've got cancer?' It was completely unexpected for them, but we didn't have the space to think about it; I just had to get started on treatment. 24 hours later, I began chemotherapy. I was able to stay surprisingly positive during the six months of treatment and tried to have a lot of fun. I'd fundraise, have chemo parties, and whenever I went out, I was always silly about being bald. When I finally got the all-clear a few months later, I couldn't wait to enjoy my life again. 'Skin irritations and problems such as dry, sore and itchy skin can be a symptom of lymphoma,' the Lymphoma Action charity explains. 'Scientists think that itching as a symptom of lymphoma might develop because of cytokines. These are proteins released by your immune system when your body is fighting an infection or an illness, like lymphoma. It's thought that cytokines cause itching by irritating the nerves in your skin. 'Skin problems often start to go away once treatment for lymphoma starts.' Itchy skin is not always a sign of anything serious. You can often treat it yourself, and it will usually go away after a few weeks, but see a GP if you're worried or the problem persists. My parents and I were so confident I would be fine when I went for a routine check-up scan in June 2019 that we dressed up nicely for a celebratory lunch afterwards. Then the doctor told me: 'I'm afraid it's back.' It was shocking news, but we kept our restaurant reservation as I'd already learnt that you must enjoy life whenever you can. I knew I might not be well enough to go out soon. I enjoyed a few drinks and saw Jude Law, so that was fun! The severity of my new cancer meant I needed a stem cell transplant, which replaces damaged or diseased blood-forming cells with healthy ones. When I had it in October 2019, I couldn't leave the hospital – even to go outside – for nearly five weeks. I was also more unwell and didn't have any energy to make it a fun experience, like last time. When it came to shaving my head again, I remember my mum's tearful face in the corner of the bathroom, and snapping at her because I didn't want to see or feel any emotion. In some ways, my illness was even harder for my parents. Some days, I was in so much pain it felt like there were little shards of glass floating around my body, and all they could do was sit and watch. Their lives were put on hold every day, not knowing if their daughter would make it. Three months after my stem cell transplant, I had a scan which showed the cancer had gone. My procedure meant that my chances of having kids became around 0.1%, but I had no choice – what's the point in being fertile if I wasn't going to be alive? However, when I started feeling better, reality hit. I always wanted to be a mum, and began grieving for the kids I'll never get to have. The transplant also put me through menopause at just 29, which was tough as the doctors didn't explain it to me, and I didn't realise what was happening. At first, I thought I was having a mental breakdown. My emotions were all over the place, my anxiety was crazy, and I was so low. I was also suffering from night sweats, sore joints and brain fog. Once I put my iron in the fridge. I was lucky to have a therapist who helped me through these life changes and eventually made the connection for me. I was put back on the pill for oestrogen, but it was suggested I come off because I had strokes. The pill can lead to an increased risk of blood clots and further strokes. So now, age 32, I've been hit by another wave of menopause symptoms, which can be difficult because none of my friends are at this stage and, as lovely and supportive as they are, they don't entirely understand it. A few months after the stem cell transplant, I went back to my job as an executive assistant at a recruitment company. They'd been so brilliant with me while I was ill, but in the end, I left so I could concentrate on my social media. I'd used it as a way to let people know how I was getting on with the diagnosis and treatment, but I also wanted to share my experience in case it could help someone else feel less alone. I hadn't known anyone my age who had been sick, so I had no one I could ask about little things, such as how to tie a headscarf or protect my nails in chemo, or talk about the big stuff, like fears. I wanted to change that and now I have nearly 100k followers and the most wonderful community who are all kind, empowering, encouraging and understanding. It's also spurred me to start my own business, Life's for Living, a travel company that takes women on adventure trips. Everyone's there for a reason, whether they've had a health issue, they're going through a divorce, they've struggled mentally, or they've been feeling insecure in their bodies. It's so incredible to bring everyone together. We bond, and it becomes beautiful. Having cancer means time feels like a precious thing, and now I want to do as much as I can. But my mum reminds me I can say 'no' sometimes. For a while, I'd give a panicked yes to everything and get burned out. It sounds cheesy, but I've realised that saying yes isn't just for the big things. I used to only light candles for nice occasions, but now I light them whenever I want. It's not feasible to have some big bucket list trip every day, so I try to remind people it's about the little things too. Last year, I had a party to raise money for The Royal Marsden Hospital and celebrate being five years cancer-free. More Trending What most people didn't know was that I was still waiting to find out if it had come back, after an inconclusive scan. I felt as if I was cheating by celebrating, so I've never felt such relief when I got the all clear. I never like to thank cancer for stuff, because I don't think it deserves the credit, but I also know that without it, I wouldn't be who I am now. You can follow Georgie Swallow on Instagram here. As told to Josie Copson Hodgkin lymphoma is an uncommon cancer that develops in the lymphatic system, which is a network of vessels and glands spread throughout your body. It can develop at any age, but it mostly affects people aged between 20-40 and those over 75. Around 2,100 people are diagnosed with Hodgkin lymphoma in the UK each year. The most common symptom of Hodgkin lymphoma is a painless swelling in a lymph node, usually in the neck, armpit or groin. Around 8 out of 10 people with Hodgkin lymphoma live at least 5 years, and most of these will be cured. However, there's a risk of long-term problems after treatment, including infertility and an increased risk of developing another type of cancer in the future. Information taken from the NHS website Do you have a story you'd like to share? Get in touch by emailing Share your views in the comments below. View More » MORE: Meet Britain's Doomsday preppers stockpiling for World War Three MORE: I attended the UK's biggest true crime convention — it wasn't what I expected MORE: 'I'd rather they killed us' How rape became a weapon in war Your free newsletter guide to the best London has on offer, from drinks deals to restaurant reviews.
ITV News
15-06-2025
- ITV News
New leukaemia treatment hailed as ‘milestone' for patients
Scientists have hailed a 'milestone' in leukaemia care for patients after a UK trial found a chemotherapy-free approach to treatment may lead to better outcomes for some patients. The groundbreaking UK-wide trial could reshape the way the most common form of leukaemia in adults is treated. Researchers from Leeds wanted to assess whether two targeted cancer drugs could perform better than standard chemotherapy among patients with chronic lymphocytic leukaemia (CLL). They led the Flair trial, which took place at 96 cancer centres across the UK. Flair trial is a milestone. We have shown that a chemotherapy-free approach can be not only more effective but also more tolerable for patients Dr Talha Munir Some 786 people with previously untreated CLL were randomly assigned to receive standard chemotherapy; a single targeted drug, ibrutinib, or two targeted drugs taken together, ibrutinib and venetoclax, with treatment guided by personalised blood tests. They found that after five years, 94% of patients who received ibrutinib plus venetoclax were alive with no disease progression. This compares with 79% for those on ibrutinib alone and 58% for those on standard chemotherapy, according to the study, which has been published in the New England Journal of Medicine and presented to the European Haematology Association congress in Milan, Italy. Meanwhile 66% of patients on the new combination had no detectable cancer in their bone marrow after two years, compared with none of the people who received ibrutinib alone and 48% on chemotherapy. Ibrutinib is a type of drug known as a cancer growth blocker. It works by stopping signals that cancer cells use to divide and grow. And venetoclax blocks the functions of a protein found in CLL cells. Experts said that the new treatment regime was also tolerated better than traditional treatments. Dr Talha Munir, consultant haematologist at Leeds Teaching Hospitals NHS Trust, who led the study said: 'Flair trial is a milestone. 'We have shown that a chemotherapy-free approach can be not only more effective but also more tolerable for patients. 'By tailoring individualised treatment based on how well the cancer responds, we're moving into an era of truly personalised medicine.' Catherine Whitfield, 63, from Farnley, West Yorkshire, was diagnosed with CLL in 2018 after she noticed symptoms including bleeding gums, constant illness and neck pain. She signed up to the trial, which was co-ordinated by the Leeds Cancer Research UK Clinical Trials Unit at the University of Leeds and sponsored by the University of Leeds. She said: 'After three years of treatment, I am still MRD negative – that means no cancer cells.' 'I lost my husband to cancer. I have seen how hard it could be. 'My first thought after my diagnosis was, I will never see my grandchildren being born and growing up. 'Now I have two grandchildren, Drew and Alaia, and they are a delight and highlight the joys of a healthy life'. Ms Whitfield added: 'The way this trial was explained, it just made sense. 'Also, the thought of chemotherapy was scary to me. The trial felt right. And it was.' Dr Iain Foulkes, executive director of research and innovation at Cancer Research UK, which funded the trial along with AbbVie, and Johnson and Johnson, said: 'The results of the Flair trial show that we can provide kinder, more targeted treatment for chronic lymphocytic leukaemia, which gives people with CLL more precious time with their loved ones. 'We're hopeful that the results of the Flair trial will power new treatment options for leukaemia and other blood cancers, thanks to the efforts of researchers at in Leeds and across the UK working together on this trial.' Chronic lymphocytic leukaemia is the most common form of leukaemia in adults. There are about 4,000 new CLL cases in the UK every year.
Scottish Sun
10-06-2025
- Scottish Sun
The 2-second at-home test that can reveal your risk of 8 nasty conditions – including killer stroke and Alzheimer's
Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) A TEST you can do at home in matter of seconds - with a bag of sugar, an air fryer or even a pet - could reveal your risk eight diseases. Do you have difficulty picking up an object weighing 5 kilograms after a certain age? Sign up for Scottish Sun newsletter Sign up 1 Declining muscle strength is linked to a higher risk of dementia or stroke Credit: Getty If so, you run the risk of developing conditions such as chronic lung disease, arthritis, stroke and Alzheimer's disease, according to researchers from the University of Sharjah in the United Arab Emirates. As we get older, our muscles naturally weaken. Muscle and hand grip strength have long been used as indicators of disease risk and can serve as a warning of declining health. But the current tools used by doctors can be expensive, meaning only clinics can afford them. Researchers set out find a simpler and more accessible method of assessing muscle strength without the use of specialised tools - finding that objects lying around at home can also be reliable indicators. Professor Rizwan Qaisar, the study's first author, said: "Imagine you're at home, and you pick up a bag of groceries, maybe something that weighs about 5 kg - like a big bag of sugar or a small kitchen appliance. "If you find yourself struggling with that, it might seem like a small thing, but our research shows it could be a really important clue about your health." Scientists conducted their investigation using data from 51,536 adults from 15 countries who were aged 50 and older. "We tracked them over time to see if their ability to lift 5 kg was connected to developing various health conditions in the future. What we found was quite significant," Prof Qaisar said. "People who reported difficulty lifting 5 kg had a significantly higher risk of experiencing a lower quality of life, higher rates of depression, chronic lung diseases, hip fractures, joint disorders, high cholesterol, Alzheimer's disease, stroke, and osteoarthritis. 10 second one leg stand test "Interestingly, this connection held regardless of their age or gender. "Our findings strongly suggest that this simple, everyday test could be a valuable early indicator of overall health and potential future health challenges." Researchers conducted their study over a five year period. Participants were asked to report if they had any difficulty doing various everyday activities at the outset of the study, as well their age, gender and country of residence. Those who had one of the diseases in question at the start of the study were excluded from analysis. One of the activities was 'lifting or carrying weights over 5 kilos', which became the central point of the researchers' analysis. "The 5kg threshold was selected due to its relevance to everyday household objects, such as a standard bag of sugar or all-purpose flour, an average house cat, an air fryer, a portable slow cooker, and the cast iron Dutch oven," they wrote. "Thus, the study provides a practical and accessible measure of muscle strength and overall health within the domestic environment." Ways to improve your strength A strength exercise is any activity that makes your muscles work harder than usual. This increases your muscles' strength, size, power and endurance. The activities involve using your body weight or working against a resistance. You should try to do two sessions or more of muscle strengthening exercises a week. Examples of muscle-strengthening activities include: Lifting weights Working with resistance bands Heavy gardening, such as digging and shovelling Climbing stairs Hill walking Cycling Dance Push-ups, sit-ups and squats Yoga Source: NHS Study participants were also asked to fill out a quality of life questionnaire - which included such as 'how often do you think your age prevents you from doing the things you would like to do?' - and had symptoms of depression assessed too. From the 51,536 respondents, 10,025 (19.5 per cent) had difficulty lifting 5kg at the start of the study. Over the follow-up period, researchers found that people who had difficulty picking up 5kg objects had a higher risk of reporting a low quality of life (9 per cent), depression (8 per cent) and osteoarthritis (7 per cent). They also had a mild to moderate risks of having "rheumatoid arthritis, heart attack, diabetes mellitus, hypertension, Alzheimer's disease, stroke, or hip fracture", according to researchers. Study authors found that women had a higher risk of various diseases than men. They said muscle weakness could be indicative of several things. "First, muscle weakness in these participants suggests a sedentary lifestyle and low physical activity, which are risk factors for several diseases reported here. "For example, a sedentary lifestyle is associated with higher risks of depression, cardiovascular diseases, metabolic disorders, and neurological deficits. "Participants with difficulty lifting 5kg will likely exhibit muscle wasting," they went on. "Muscle mass is a significant protein reserve that protects against organ degeneration due to trauma, diseases, and/or ageing. Thus, a low muscle mass in the participants with difficulty lifting 5kg of weight can predispose them to develop chronic diseases." Finally, muscle weakness could be connected to inflammation. "It is also established that chronic low-grade inflammation can cause and/or exacerbate various cardiovascular, neurological, and metabolic disorders reported in this study," researchers stated. Study co-author Dr Fabio Franzese from SHARE Berlin Institute in Germany, said: "Muscle weakness isn't just a sign of ageing; it's a profound warning for future disease." That's why the "simple act" of trying pick up 5kg with "no fancy equipment" can be "a powerful health predictor". "Our findings put early health assessment in everyone's hands," he said. Prof Qaisar added: "Before major illness, there's often a subtle struggle. This test offers a crucial window for intervention. "The test empowers people to seek early medical advice, motivates healthier lifestyle choices, and offers health care providers a valuable preliminary screening tool to identify at-risk individuals, ultimately improving preventive care and public health outreach for older populations."
